[{"title":"Biomarkers of response to PD-1/PD-L1 inhibition","googleId":"ETaTE4u-DAoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303493","googleCitationCount":173,"googleAuthor":"I Duran","doi":"10.1016/j.critrevonc.2017.06.001","elsevierAuthor":"Maleki Vareki S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"121"},{"title":"E-cadherin: Its dysregulation in carcinogenesis and clinical implications","googleId":"F1hCoEaIHOUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730224X","googleCitationCount":144,"googleAuthor":"CM Fang","doi":"10.1016/j.critrevonc.2017.11.010","elsevierAuthor":"Wong S.H.M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"104"},{"title":"FGFR a promising druggable target in cancer: Molecular biology and new drugs","googleId":"5p8nol0NDpYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300859","googleCitationCount":149,"googleAuthor":"S Khan","doi":"10.1016/j.critrevonc.2017.02.018","elsevierAuthor":"Porta R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"83"},{"title":"The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis","googleId":"pXxwJM1JwP8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301890","googleCitationCount":137,"googleAuthor":"RD Dolan","doi":"10.1016/j.critrevonc.2017.06.002","elsevierAuthor":"Dolan R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"107"},{"title":"Mechanisms and risk factors of thrombosis in cancer","googleId":"5uP8FPM3mHgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303141","googleCitationCount":111,"googleAuthor":"A Vignoli","doi":"10.1016/j.critrevonc.2017.08.003","elsevierAuthor":"Falanga A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"80"},{"title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","googleId":"aTIyZ2K2P0gJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303499","googleCitationCount":99,"googleAuthor":"BP Venkatesulu","doi":"10.1016/j.critrevonc.2018.01.003","elsevierAuthor":"Venkatesulu B.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"76"},{"title":"Drug resistance in pancreatic cancer: Impact of altered energy metabolism","googleId":"9rXxS6OqnAYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300951","googleCitationCount":86,"googleAuthor":"E Giovannetti","doi":"10.1016/j.critrevonc.2017.03.026","elsevierAuthor":"Grasso C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"73"},{"title":"Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: a systematic review","googleId":"GYSLF8odh1cJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303353","googleCitationCount":78,"googleAuthor":"F Duregon","doi":"10.1016/j.critrevonc.2017.11.002","elsevierAuthor":"Duregon F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"51"},{"title":"Epigenetic control of gene expression: Potential implications for cancer treatment","googleId":"GIaHe5SFLtgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300021","googleCitationCount":85,"googleAuthor":"F Perri","doi":"10.1016/j.critrevonc.2017.01.020","elsevierAuthor":"Perri F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"66"},{"title":"Similar but not the same: differential diagnosis of HLH and sepsis","googleId":"pFPxCQIOn3YJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301828","googleCitationCount":77,"googleAuthor":"R Machowicz","doi":"10.1016/j.critrevonc.2017.03.023","elsevierAuthor":"Machowicz R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"49"},{"title":"The unfolded protein response as a target for anticancer therapeutics","googleId":"-mdNm9G_7WUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305103","googleCitationCount":54,"googleAuthor":"RK Castellano","doi":"10.1016/j.critrevonc.2018.05.003","elsevierAuthor":"Wang M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"43"},{"title":"Cancer cachexia: diagnosis, assessment, and treatment","googleId":"SXMOV4VYQmwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302731","googleCitationCount":59,"googleAuthor":"M Sadeghi","doi":"10.1016/j.critrevonc.2018.05.006","elsevierAuthor":"Sadeghi M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"34"},{"title":"MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review","googleId":"9cFbA19nyrkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302639","googleCitationCount":72,"googleAuthor":"BK Ahir","doi":"10.1016/j.critrevonc.2017.10.003","elsevierAuthor":"Ahir B.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"56"},{"title":"Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis","googleId":"aO3-hXWWd70J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303165","googleCitationCount":67,"googleAuthor":"S Gandini","doi":"10.1016/j.critrevonc.2017.12.003","elsevierAuthor":"Gandini S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"46"},{"title":"The role of nuclear factor-kappa B signaling in human cervical cancer","googleId":"IKlBLzbuqoMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303529","googleCitationCount":110,"googleAuthor":"S Tilborghs","doi":"10.1016/j.critrevonc.2017.11.001","elsevierAuthor":"Tilborghs S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"78"},{"title":"Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review","googleId":"HR8vxZB7UsEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303803","googleCitationCount":62,"googleAuthor":"M Mohajeri","doi":"10.1016/j.critrevonc.2017.12.005","elsevierAuthor":"Mohajeri M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"48"},{"title":"Mucins: structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets","googleId":"j16y2YKv7DEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303062","googleCitationCount":62,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.12.006","elsevierAuthor":"Dhanisha S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"46"},{"title":"The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: a systematic review","googleId":"r5trVjmqML8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301744","googleCitationCount":47,"googleAuthor":"RD Dolan","doi":"10.1016/j.critrevonc.2018.09.016","elsevierAuthor":"Dolan R.D.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"34"},{"title":"Third generation EGFR TKIs in EGFR-mutated NSCLC: where are we now and where are we going","googleId":"OWoRxOlIvoQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302347","googleCitationCount":70,"googleAuthor":"A Russo","doi":"10.1016/j.critrevonc.2017.07.003","elsevierAuthor":"Russo A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"56"},{"title":"Aberrant cancer metabolism in epithelial–mesenchymal transition and cancer metastasis: mechanisms in cancer progression","googleId":"AvIJwnanna4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302268","googleCitationCount":63,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.04.005","elsevierAuthor":"Huang R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"56"},{"title":"Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy","googleId":"IMNgJE-Es4EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303985","googleCitationCount":65,"googleAuthor":"T Alonso-Gordoa","doi":"10.1016/j.critrevonc.2017.01.013","elsevierAuthor":"Martínez-Sáez O.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"39"},{"title":"Vitamin D analogues: Potential use in cancer treatment","googleId":"xug9_A8aBRcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300835","googleCitationCount":63,"googleAuthor":"MJ Duffy","doi":"10.1016/j.critrevonc.2017.02.015","elsevierAuthor":"Duffy M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"46"},{"title":"Vincristine-induced peripheral neuropathy in children with cancer: A systematic review","googleId":"vw_gNtX2-i4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301981","googleCitationCount":57,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.04.004","elsevierAuthor":"van de Velde M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"46"},{"title":"The roles of reactive oxygen species (ROS) and autophagy in the survival and death of leukemia cells","googleId":"xXVkDLyq9IUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300549","googleCitationCount":60,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.02.004","elsevierAuthor":"Chen Y.F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"46"},{"title":"Central nervous system gliomas","googleId":"pkzdI2qj1ZEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301804","googleCitationCount":76,"googleAuthor":"M Reni","doi":"10.1016/j.critrevonc.2017.03.021","elsevierAuthor":"Reni M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"54"},{"title":"Molecular targets of celastrol in cancer: Recent trends and advancements","googleId":"0X268Dk_qnIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304006","googleCitationCount":48,"googleAuthor":"D Kashyap","doi":"10.1016/j.critrevonc.2018.05.019","elsevierAuthor":"Kashyap D.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"33"},{"title":"The current value of determining the mismatch repair status of colorectal cancer: a rationale for routine testing","googleId":"LA6OkZy9ZPsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302669","googleCitationCount":76,"googleAuthor":"E Ryan","doi":"10.1016/j.critrevonc.2017.05.006","elsevierAuthor":"Ryan E.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"52"},{"title":"Genistein: Its role in metabolic diseases and cancer","googleId":"-0QWNrD0sicJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303001","googleCitationCount":88,"googleAuthor":"V Sharma","doi":"10.1016/j.critrevonc.2017.09.004","elsevierAuthor":"Mukund V.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"70"},{"title":"Clinical relevance of colorectal cancer molecular subtypes","googleId":"4XY5sIF5zCYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303237","googleCitationCount":74,"googleAuthor":"R Barderas","doi":"10.1016/j.critrevonc.2016.11.007","elsevierAuthor":"Rodriguez-Salas N.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"44"},{"title":"Mucosal melanoma of the head and neck","googleId":"P1vudnPMWa0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300458","googleCitationCount":57,"googleAuthor":"PA Ascierto","doi":"10.1016/j.critrevonc.2017.01.019","elsevierAuthor":"Ascierto P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"37"},{"title":"Effectiveness of antiangiogenic drugs in glioblastoma patients: a systematic review and meta-analysis of randomized clinical trials","googleId":"C8HxJtRQliQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302256","googleCitationCount":59,"googleAuthor":"A Pambuku","doi":"10.1016/j.critrevonc.2017.01.018","elsevierAuthor":"Lombardi G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"43"},{"title":"Frontline treatment of acute myeloid leukemia in adults","googleId":"RCoS1zACaSsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303663","googleCitationCount":72,"googleAuthor":"G Tamamyan","doi":"10.1016/j.critrevonc.2016.12.004","elsevierAuthor":"Tamamyan G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"40"},{"title":"Not all immune-checkpoint inhibitors are created equal: meta-analysis and systematic review of immune-related adverse events in cancer trials","googleId":"f4eIIJXPpfQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302354","googleCitationCount":86,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.09.002","elsevierAuthor":"El Osta B.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"64"},{"title":"Cardiotoxic effects of chemotherapy: a review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system","googleId":"b5Ev4DlsttQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303566","googleCitationCount":42,"googleAuthor":"HM Babiker","doi":"10.1016/j.critrevonc.2018.03.014","elsevierAuthor":"Babiker H.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"32"},{"title":"Global comparison of targeted alpha vs targeted beta therapy for cancer: In vitro, in vivo and clinical trials","googleId":"XEeNXPXgeUEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303608","googleCitationCount":49,"googleAuthor":"L Marcu","doi":"10.1016/j.critrevonc.2018.01.001","elsevierAuthor":"Marcu L.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"34"},{"title":"The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers","googleId":"LcwUbEiskooJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303815","googleCitationCount":41,"googleAuthor":"S Savas","doi":"10.1016/j.critrevonc.2018.01.009","elsevierAuthor":"Savas S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"34"},{"title":"Critical appraisal of oncological safety of stent as bridge to surgery in left-sided obstructing colon cancer; a systematic review and meta-analysis","googleId":"DBrTSHkMiBYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301264","googleCitationCount":38,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.08.003","elsevierAuthor":"Amelung F.J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"26"},{"title":"Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients","googleId":"7WtBKSq5Lf4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300070","googleCitationCount":55,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.01.005","elsevierAuthor":"Mehta M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"37"},{"title":"Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: A review","googleId":"r6T46ne9cCUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303268","googleCitationCount":49,"googleAuthor":"A Paix","doi":"10.1016/j.critrevonc.2018.01.011","elsevierAuthor":"Paix A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"36"},{"title":"ECCO essential requirements for quality cancer care: soft tissue sarcoma in adults and bone sarcoma. A critical review","googleId":"g2CgoHgxgEoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303614","googleCitationCount":63,"googleAuthor":"S Bonvalot","doi":"10.1016/j.critrevonc.2016.12.002","elsevierAuthor":"Andritsch E.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"44"},{"title":"Role of ketogenic metabolic therapy in malignant glioma: a systematic review","googleId":"qaenZBOuEBQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302323","googleCitationCount":62,"googleAuthor":"SF Winter","doi":"10.1016/j.critrevonc.2017.02.016","elsevierAuthor":"Winter S.F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"43"},{"title":"Radiotherapy in triple-negative breast cancer: current situation and upcoming strategies","googleId":"qedTWaILzzsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304080","googleCitationCount":31,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.09.004","elsevierAuthor":"He M.Y.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"23"},{"title":"Cholangiocarcinoma","googleId":"sj-zQoIrqPAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303365","googleCitationCount":66,"googleAuthor":"","doi":"10.1016/j.critrevonc.2016.11.012","elsevierAuthor":"Squadroni M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"43"},{"title":"Biomarkers of response to immune checkpoint blockade in cancer treatment","googleId":"TdYSYTvpW5sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301987","googleCitationCount":34,"googleAuthor":"A Naing","doi":"10.1016/j.critrevonc.2018.07.010","elsevierAuthor":"Fujii T.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"24"},{"title":"Targeting KRAS mutated non-small cell lung cancer: a history of failures and a future of hope for a diverse entity","googleId":"epUYihuxOFEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303675","googleCitationCount":60,"googleAuthor":"A Matikas","doi":"10.1016/j.critrevonc.2016.12.005","elsevierAuthor":"Matikas A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"35"},{"title":"Primary central nervous system lymphoma","googleId":"ICx_9Pjan4sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303092","googleCitationCount":47,"googleAuthor":"M Reni","doi":"10.1016/j.critrevonc.2017.03.019","elsevierAuthor":"Citterio G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"33"},{"title":"Regulatory effects of berberine on microRNome in cancer and other conditions","googleId":"ijPI5Usmt0UJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300240","googleCitationCount":46,"googleAuthor":"SH Ayati","doi":"10.1016/j.critrevonc.2017.05.008","elsevierAuthor":"Ayati S.H.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"42"},{"title":"Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: a systematic review and meta-analysis of randomized trials","googleId":"a7ubI-J83gsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303992","googleCitationCount":44,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.12.011","elsevierAuthor":"Oberoi S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"26"},{"title":"Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer","googleId":"QQcxe9FLodkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300100","googleCitationCount":48,"googleAuthor":"R Vadde","doi":"10.1016/j.critrevonc.2017.02.025","elsevierAuthor":"Vadde R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"35"},{"title":"The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership","googleId":"2MdhWHQh1TYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302608","googleCitationCount":59,"googleAuthor":"J Castelli","doi":"10.1016/j.critrevonc.2017.01.017","elsevierAuthor":"Chajon E.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"44"},{"title":"Melatonin and breast cancer: Evidences from preclinical and human studies","googleId":"5DiKeaGyOL0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300884","googleCitationCount":46,"googleAuthor":"P Kubatka","doi":"10.1016/j.critrevonc.2017.12.018","elsevierAuthor":"Kubatka P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"32"},{"title":"Reviewing the current evidence supporting early B-cells as the cellular origin of Merkel cell carcinoma","googleId":"MmWYmGtuqUQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302207","googleCitationCount":44,"googleAuthor":"E Chteinberg","doi":"10.1016/j.critrevonc.2017.05.009","elsevierAuthor":"Sauer C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"33"},{"title":"Triplet (FOLFOXIRI) versus doublet (FOLFOX or FOLFIRI) backbone chemotherapy as first-line treatment of metastatic colorectal cancer: A systematic review and meta …","googleId":"tNtHRVoV604J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302955","googleCitationCount":41,"googleAuthor":"GS Duarte","doi":"10.1016/j.critrevonc.2017.08.006","elsevierAuthor":"Marques R.P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"26"},{"title":"A comprehensive review of immunotherapies in prostate cancer","googleId":"DBykxtjxo9sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300239","googleCitationCount":46,"googleAuthor":"MC Maia","doi":"10.1016/j.critrevonc.2017.02.026","elsevierAuthor":"Maia M.C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"34"},{"title":"Biomarkers in prostate cancer–current clinical utility and future perspectives","googleId":"fRZi6n-vbJQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303785","googleCitationCount":69,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.11.007","elsevierAuthor":"Kretschmer A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"50"},{"title":"Immune-checkpoint inhibitors in non-small cell lung cancer: a tool to improve patients' selection","googleId":"EmSQa6y7pmgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300866","googleCitationCount":31,"googleAuthor":"GL Banna","doi":"10.1016/j.critrevonc.2018.06.016","elsevierAuthor":"Banna G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"25"},{"title":"Efficacy and safety of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis","googleId":"UbKChYiVLagJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302943","googleCitationCount":46,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.02.017","elsevierAuthor":"Yoodee J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"25"},{"title":"The see-saw of Keap1-Nrf2 pathway in cancer","googleId":"PdQclmaunF4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300562","googleCitationCount":44,"googleAuthor":"AK Singh","doi":"10.1016/j.critrevonc.2017.02.006","elsevierAuthor":"Pandey P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"33"},{"title":"The stem cell division theory of cancer","googleId":"iHLPxD3qHPMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303669","googleCitationCount":43,"googleAuthor":"M López-Lázaro","doi":"10.1016/j.critrevonc.2018.01.010","elsevierAuthor":"López-Lázaro M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"21"},{"title":"Glutathione system in animal model of solid tumors: From regulation to therapeutic target","googleId":"va_1eaRv6bcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305012","googleCitationCount":36,"googleAuthor":"A Acco","doi":"10.1016/j.critrevonc.2018.05.014","elsevierAuthor":"Corso C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"23"},{"title":"The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment","googleId":"FDk9QDlB8NEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304134","googleCitationCount":35,"googleAuthor":"G Bogani","doi":"10.1016/j.critrevonc.2017.12.017","elsevierAuthor":"Bogani G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"24"},{"title":"Lymphoblastic lymphoma","googleId":"_z37n9HsxTgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302438","googleCitationCount":48,"googleAuthor":"D Hoelzer","doi":"10.1016/j.critrevonc.2017.03.020","elsevierAuthor":"Cortelazzo S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"29"},{"title":"Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: a systematic review","googleId":"vHe1OMP37ekJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303979","googleCitationCount":60,"googleAuthor":"A Garant","doi":"10.1016/j.critrevonc.2017.10.009","elsevierAuthor":"Garant A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"47"},{"title":"The role of heme iron molecules derived from red and processed meat in the pathogenesis of colorectal carcinoma","googleId":"PiTeI2PqLRsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302573","googleCitationCount":30,"googleAuthor":"SMK Gamage","doi":"10.1016/j.critrevonc.2018.03.025","elsevierAuthor":"Gamage S.M.K.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"19"},{"title":"Polymerase proofreading domain mutations: new opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency","googleId":"QyElGLL38CkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303158","googleCitationCount":46,"googleAuthor":"B Rousseau","doi":"10.1016/j.critrevonc.2017.03.027","elsevierAuthor":"Bourdais R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"40"},{"title":"Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug–drug interactions","googleId":"OvnxSzh_-tMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730210X","googleCitationCount":25,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.09.015","elsevierAuthor":"Riess H.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"25"},{"title":"Crosstalk in cancer resistance and metastasis","googleId":"QI5hMXre4LsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301999","googleCitationCount":25,"googleAuthor":"S Norouzi","doi":"10.1016/j.critrevonc.2018.09.017","elsevierAuthor":"Norouzi S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"21"},{"title":"Ionizing radiation-induced cellular senescence promotes tissue fibrosis after radiotherapy. A review","googleId":"JxrZI2KrgjEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300854","googleCitationCount":30,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.06.012","elsevierAuthor":"Nguyen H.Q.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"24"},{"title":"Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review","googleId":"QiOyR_gyXJMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730149X","googleCitationCount":33,"googleAuthor":"M Loi","doi":"10.1016/j.critrevonc.2017.10.011","elsevierAuthor":"Bonomo P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"28"},{"title":"Surgical treatment of pulmonary metastasis in colorectal cancer patients: Current practice and results","googleId":"aSk5lZi-mGoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305048","googleCitationCount":32,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.05.001","elsevierAuthor":"Zellweger M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"24"},{"title":"Salivary biomarkers in the diagnosis of breast cancer: A review","googleId":"Lk5mz3KzP8UJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303882","googleCitationCount":48,"googleAuthor":"","doi":"10.1016/j.critrevonc.2016.12.009","elsevierAuthor":"Porto-Mascarenhas E.C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"33"},{"title":"Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives","googleId":"Y67mLmuMSVUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304146","googleCitationCount":31,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.01.013","elsevierAuthor":"Tomasello C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"22"},{"title":"Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic review","googleId":"x2IA_yCDgiAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281830043X","googleCitationCount":26,"googleAuthor":"P Spychalski","doi":"10.1016/j.critrevonc.2018.06.005","elsevierAuthor":"Kobiela J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"23"},{"title":"Primary mediastinal large B-cell lymphoma","googleId":"0E2jwqDUG3gJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281630244X","googleCitationCount":44,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.01.009","elsevierAuthor":"Martelli M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"26"},{"title":"Ponatinib in chronic myeloid leukemia (CML): Consensus on patient treatment and management from a European expert panel","googleId":"xMa33iVBAf4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300677","googleCitationCount":33,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.10.002","elsevierAuthor":"Müller M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"19"},{"title":"Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): does biological rationale meet clinical needs?","googleId":"l5E4qMBI7x0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302743","googleCitationCount":35,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.09.007","elsevierAuthor":"Attili I.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"28"},{"title":"Mast cells in breast cancer angiogenesis","googleId":"jOWQGiWJwzAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730118X","googleCitationCount":38,"googleAuthor":"AM Cimpean","doi":"10.1016/j.critrevonc.2017.04.009","elsevierAuthor":"Cimpean A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"27"},{"title":"Brentuximab vedotin for treatment of non-Hodgkin lymphomas: a systematic review","googleId":"HrAehnPl03sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303262","googleCitationCount":41,"googleAuthor":"","doi":"10.1016/j.critrevonc.2016.11.009","elsevierAuthor":"Berger G.K.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"33"},{"title":"CDK4/6 inhibitors in HER2-positive breast cancer","googleId":"B6bvk-IwVcsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281630333X","googleCitationCount":35,"googleAuthor":"D Cretella","doi":"10.1016/j.critrevonc.2017.02.022","elsevierAuthor":"Corona S.P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"26"},{"title":"Radioiodine refractory differentiated thyroid cancer","googleId":"KvK21dlilZUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303311","googleCitationCount":25,"googleAuthor":"Y Jin","doi":"10.1016/j.critrevonc.2018.03.012","elsevierAuthor":"Jin Y.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"16"},{"title":"Long non-coding RNA CASC2 in human cancer","googleId":"Idan_yyohq4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302402","googleCitationCount":40,"googleAuthor":"G Palmieri","doi":"10.1016/j.critrevonc.2017.01.003","elsevierAuthor":"Palmieri G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"38"},{"title":"Evolution in sentinel lymph node biopsy in breast cancer","googleId":"rdw8M0XrkuUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300355","googleCitationCount":32,"googleAuthor":"GJ Zhang","doi":"10.1016/j.critrevonc.2017.09.010","elsevierAuthor":"Qiu S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"19"},{"title":"Antinuclear antibodies and cancer: a literature review","googleId":"PmoLwzcCvI4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305486","googleCitationCount":29,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.05.002","elsevierAuthor":"Vlagea A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"15"},{"title":"Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies","googleId":"4evnRY2HDhoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304110","googleCitationCount":29,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.12.013","elsevierAuthor":"Wang C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"13"},{"title":"Circulating tumour DNA, a promising biomarker for the management of colorectal cancer","googleId":"v-FLbTKc1S8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303542","googleCitationCount":29,"googleAuthor":"M Gerlinger","doi":"10.1016/j.critrevonc.2017.12.002","elsevierAuthor":"Khakoo S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"21"},{"title":"Chondrosarcoma: an overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets","googleId":"ZkQIKegbUKIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300416","googleCitationCount":21,"googleAuthor":"K Majidzadeh-A","doi":"10.1016/j.critrevonc.2018.09.001","elsevierAuthor":"Nazeri E.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"16"},{"title":"Lipid metabolism and lung cancer","googleId":"uJHTylLl9m8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300513","googleCitationCount":35,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.02.001","elsevierAuthor":"Salvador M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"0"},{"title":"Prognostic and predictive biomarkers in neuroendocrine tumours","googleId":"4VZtzdRewosJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302670","googleCitationCount":34,"googleAuthor":"DL Chan","doi":"10.1016/j.critrevonc.2017.03.017","elsevierAuthor":"Chan D.L.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"20"},{"title":"Towards personalized medicine of colorectal cancer","googleId":"N4gqRwo6UocJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281630364X","googleCitationCount":29,"googleAuthor":"MA Aziz","doi":"10.1016/j.critrevonc.2017.08.007","elsevierAuthor":"Aziz M.A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"19"},{"title":"Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequences","googleId":"z0KjFfTP8YoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304341","googleCitationCount":24,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.06.015","elsevierAuthor":"Bellesoeur A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"19"},{"title":"Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta …","googleId":"L4rsYjxtFAAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302762","googleCitationCount":21,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.09.018","elsevierAuthor":"Marchetti C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"16"},{"title":"An attempt to conceptualize the individual onco-functional balance: why a standardized treatment is an illusion for diffuse low-grade glioma patients","googleId":"WZT7VeZQz0kJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304158","googleCitationCount":31,"googleAuthor":"E Mandonnet","doi":"10.1016/j.critrevonc.2017.12.008","elsevierAuthor":"Mandonnet E.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"24"},{"title":"Genomics and pharmacogenomics of pediatric acute lymphoblastic leukemia","googleId":"O3PtIpVLBo4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301008","googleCitationCount":24,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.04.002","elsevierAuthor":"Wu C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"17"},{"title":"Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy","googleId":"lF3bZlpAs2AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303219","googleCitationCount":47,"googleAuthor":"M Porcu","doi":"10.1016/j.critrevonc.2017.09.017","elsevierAuthor":"Solinas C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"38"},{"title":"Re-irradiation as salvage treatment in recurrent glioblastoma: a comprehensive literature review to provide practical answers to frequently asked questions","googleId":"DWLqJ8w0n4oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302433","googleCitationCount":24,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.024","elsevierAuthor":"Scoccianti S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"16"},{"title":"TERT promoter mutation and its interaction with IDH mutations in glioma: combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct …","googleId":"aDx9zPeb9HMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301956","googleCitationCount":30,"googleAuthor":"HG Vuong","doi":"10.1016/j.critrevonc.2017.09.013","elsevierAuthor":"Vuong H.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"22"},{"title":"Mechanisms of chemotherapy-induced ovarian damage in breast cancer patients","googleId":"4YZJSK7tczcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301579","googleCitationCount":31,"googleAuthor":"G Codacci-Pisanelli","doi":"10.1016/j.critrevonc.2017.03.009","elsevierAuthor":"Codacci-Pisanelli G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"20"},{"title":"Cognitive impairment and chemotherapy: a brief overview","googleId":"kcoKFFO9f6IJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730389X","googleCitationCount":49,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.08.001","elsevierAuthor":"Vitali M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"32"},{"title":"Cancer-related fatigue in adolescents and young adults: A systematic review of the literature","googleId":"Ut0mUFgqim4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302335","googleCitationCount":29,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.08.004","elsevierAuthor":"Nowe E.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"0"},{"title":"Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectives","googleId":"SCqCQnaKP3oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303912","googleCitationCount":24,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.01.002","elsevierAuthor":"Vernieri C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"21"},{"title":"Urinary biomarkers in prostate cancer detection and monitoring progression","googleId":"mk4Z8HV5S0wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302512","googleCitationCount":48,"googleAuthor":"D Wu","doi":"10.1016/j.critrevonc.2017.08.002","elsevierAuthor":"Wu D.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"32"},{"title":"Radiosurgery for intracranial meningiomas: a systematic review and meta-analysis","googleId":"lVQPm2j42sEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301555","googleCitationCount":31,"googleAuthor":"M Rizzi","doi":"10.1016/j.critrevonc.2017.03.005","elsevierAuthor":"Pinzi V.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"23"},{"title":"Azacitidine in adult patients with acute myeloid leukemia","googleId":"l96T8R3TX0gJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301130","googleCitationCount":34,"googleAuthor":"H Döhner","doi":"10.1016/j.critrevonc.2017.05.010","elsevierAuthor":"Schuh A.C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"26"},{"title":"Melanoma: last call for radiotherapy","googleId":"9DLuqk46izwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303651","googleCitationCount":34,"googleAuthor":"","doi":"10.1016/j.critrevonc.2016.12.003","elsevierAuthor":"Espenel S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"27"},{"title":"Circulating tumor cells count as a predictor of survival in lung cancer","googleId":"pehjGcOJ5-oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300039","googleCitationCount":22,"googleAuthor":"K Syrigos","doi":"10.1016/j.critrevonc.2018.03.004","elsevierAuthor":"Syrigos K.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"17"},{"title":"Specificity protein 1: its role in colorectal cancer progression and metastasis","googleId":"JtmDhOPW7eMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816304048","googleCitationCount":31,"googleAuthor":"R Bajpai","doi":"10.1016/j.critrevonc.2017.02.024","elsevierAuthor":"Bajpai R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"20"},{"title":"ECCO essential requirements for quality cancer care: colorectal cancer. A critical review","googleId":"gXwVRMU1mmgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303547","googleCitationCount":35,"googleAuthor":"D Sebag-Montefiore","doi":"10.1016/j.critrevonc.2016.12.001","elsevierAuthor":"Beets G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"22"},{"title":"Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects","googleId":"eoj1xTqH4uAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303505","googleCitationCount":23,"googleAuthor":"M Moschetta","doi":"10.1016/j.critrevonc.2017.10.007","elsevierAuthor":"Boussios S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"12"},{"title":"Prognostic and predictive factors in patients with brain metastases from solid tumors: a review of published nomograms","googleId":"0901fCuO9KYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305152","googleCitationCount":23,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.018","elsevierAuthor":"Nieder C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"18"},{"title":"Management of metastatic castration-resistant prostate cancer: a focus on radium-223: opinions and suggestions from an expert multidisciplinary panel","googleId":"SnXs-s9Xq_gJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302220","googleCitationCount":28,"googleAuthor":"G Boni","doi":"10.1016/j.critrevonc.2017.03.001","elsevierAuthor":"Baldari S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"17"},{"title":"How have evolutions in strategies for the treatment of relapsed/refractory multiple myeloma translated into improved outcomes for patients?","googleId":"CeGf9jTJFlkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300604","googleCitationCount":33,"googleAuthor":"P Moreau","doi":"10.1016/j.critrevonc.2017.02.007","elsevierAuthor":"Sonneveld P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"18"},{"title":"Venous thromboembolism in radiation therapy cancer patients: findings from the RIETE registry","googleId":"NlB5QpkJAC8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301543","googleCitationCount":28,"googleAuthor":"L Bertoletti","doi":"10.1016/j.critrevonc.2017.03.006","elsevierAuthor":"Guy J.B.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"20"},{"title":"Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: an overview about well-established and recently …","googleId":"2UTc-4v1x9wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730313X","googleCitationCount":44,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.11.005","elsevierAuthor":"Lalami Y.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"30"},{"title":"Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: An overview of systematic reviews with meta-analyses","googleId":"S9aqmkNh8jkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301749","googleCitationCount":30,"googleAuthor":"PM Aguiar","doi":"10.1016/j.critrevonc.2017.03.014","elsevierAuthor":"Aguiar P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"15"},{"title":"The effects of mitochondria-associated long noncoding RNAs in cancer mitochondria: New players in an old arena","googleId":"actod60iqQ4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301653","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.08.005","elsevierAuthor":"Zhao Y.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"17"},{"title":"Systemic treatment in adult uterine sarcomas","googleId":"RBMmTwk04LoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304912","googleCitationCount":22,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.12.009","elsevierAuthor":"Desar I.M.E.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"11"},{"title":"Do alcoholic beverages, obesity and other nutritional factors modify the risk of familial colorectal cancer? A systematic review","googleId":"frfOpHgBEq8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301695","googleCitationCount":25,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.09.001","elsevierAuthor":"Fardet A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"19"},{"title":"ECCO essential requirements for quality cancer care: Melanoma","googleId":"achBbKiQsmwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305760","googleCitationCount":22,"googleAuthor":"MW Wouters","doi":"10.1016/j.critrevonc.2017.12.020","elsevierAuthor":"Wouters M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"12"},{"title":"Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: a review of the literature","googleId":"ftUv1riMgN0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301737","googleCitationCount":26,"googleAuthor":"G Gullo","doi":"10.1016/j.critrevonc.2017.03.013","elsevierAuthor":"Losurdo A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"21"},{"title":"Effects of prehabilitation and rehabilitation including a home-based component on physical fitness, adherence, treatment tolerance, and recovery in patients with non …","googleId":"eOqxtbMO7a4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303638","googleCitationCount":30,"googleAuthor":"BC Bongers","doi":"10.1016/j.critrevonc.2017.03.031","elsevierAuthor":"Driessen E.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"20"},{"title":"Biological aspects of chondrosarcoma: leaps and hurdles","googleId":"kbaLoGfjvJUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303797","googleCitationCount":25,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.009","elsevierAuthor":"Mery B.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"22"},{"title":"Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis","googleId":"w8cQAJ5hocsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303438","googleCitationCount":18,"googleAuthor":"FE Vera-Badillo","doi":"10.1016/j.critrevonc.2018.05.005","elsevierAuthor":"Gregg R.W.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"15"},{"title":"Revisiting the dynamic cancer stem cell model: Importance of tumour edges","googleId":"jlGD9uY0Fu0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302531","googleCitationCount":19,"googleAuthor":"P Hernández-Camarero","doi":"10.1016/j.critrevonc.2018.08.004","elsevierAuthor":"Hernández-Camarero P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"10"},{"title":"Effect of long term aspirin use on the incidence of prostate cancer: a systematic review and meta-analysis","googleId":"2QkM-aKtCp8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818303081","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.09.013","elsevierAuthor":"Sauer C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"9"},{"title":"Antiangiogenic therapy: markers of response,“normalization” and resistance","googleId":"9UQ1liIfcb4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304171","googleCitationCount":20,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.06.001","elsevierAuthor":"El Alaoui-Lasmaili K.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"16"},{"title":"Epigenetic regulation of the Hedgehog and Wnt pathways in cancer","googleId":"rg7k3CSduzEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303463","googleCitationCount":20,"googleAuthor":"MF Bijlsma","doi":"10.1016/j.critrevonc.2017.11.013","elsevierAuthor":"Wils L.J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"14"},{"title":"Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A …","googleId":"pXxTxDg0UX0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302737","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.09.007","elsevierAuthor":"Montes de Jesus F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"8"},{"title":"Proton pump inhibitors in cancer patients: how useful they are? A review of the most common indications for their use","googleId":"vfdcVTCgkFQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302281","googleCitationCount":28,"googleAuthor":"P Franco","doi":"10.1016/j.critrevonc.2017.01.014","elsevierAuthor":"Numico G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"24"},{"title":"Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies","googleId":"UR5QS6qbiw0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303924","googleCitationCount":29,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.03.002","elsevierAuthor":"Leitch H.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"22"},{"title":"Fertility preserving options for gynecologic malignancies: A review of current understanding and future directions","googleId":"-f6YeFiw8vAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818303688","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.09.020","elsevierAuthor":"McKenzie N.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"11"},{"title":"How could breast cancer molecular features contribute to locoregional treatment decision making?","googleId":"Tga9PuBbjEwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303687","googleCitationCount":29,"googleAuthor":"PG Tsoutsou","doi":"10.1016/j.critrevonc.2016.12.006","elsevierAuthor":"Tsoutsou P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"23"},{"title":"Melanoma antigens and related immunological markers","googleId":"dz32mwywE6IJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301993","googleCitationCount":41,"googleAuthor":"E Aizenshtein","doi":"10.1016/j.critrevonc.2017.05.001","elsevierAuthor":"Pitcovski J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"25"},{"title":"The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy","googleId":"F-MKAKRWlY4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300994","googleCitationCount":17,"googleAuthor":"A Russo","doi":"10.1016/j.critrevonc.2018.06.007","elsevierAuthor":"Russo A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"14"},{"title":"Fluoropyrimidine-induced cardiotoxicity","googleId":"bxLFfFsSQHkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302652","googleCitationCount":18,"googleAuthor":"C Cagnazzo","doi":"10.1016/j.critrevonc.2018.02.002","elsevierAuthor":"Depetris I.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"15"},{"title":"Immune check-point in cervical cancer","googleId":"TF1vt3jmUPwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301185","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.06.006","elsevierAuthor":"De Felice F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"17"},{"title":"Understanding c-MET signalling in squamous cell carcinoma of the head & neck","googleId":"R97G-fvk4LsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300057","googleCitationCount":29,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.01.004","elsevierAuthor":"Szturz P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"23"},{"title":"The Era of PARP inhibitors in ovarian cancer:“Class Action” or not? A systematic review and meta-analysis","googleId":"N3nwKtZj3DcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302506","googleCitationCount":19,"googleAuthor":"D Ciliberto","doi":"10.1016/j.critrevonc.2018.08.011","elsevierAuthor":"Staropoli N.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"14"},{"title":"Comparison of whole body magnetic resonance imaging (WBMRI) to whole body computed tomography (WBCT) or 18F-fluorodeoxyglucose positron emission …","googleId":"AHq20dRaAncJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305413","googleCitationCount":21,"googleAuthor":"H Verma","doi":"10.1016/j.critrevonc.2018.02.012","elsevierAuthor":"Gariani J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"15"},{"title":"Optimization and purification of l-asparaginase from fungi: A systematic review","googleId":"AFEU_oZdJ6AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302640","googleCitationCount":22,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.11.006","elsevierAuthor":"Souza P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"12"},{"title":"Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy","googleId":"nubf0pIcgU8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300350","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.09.012","elsevierAuthor":"Taourel P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"10"},{"title":"Management of adverse events during treatment of gastrointestinal cancers with epidermal growth factor inhibitors","googleId":"iJ0JZlgcxikJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303869","googleCitationCount":24,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.03.032","elsevierAuthor":"Hofheinz R.D.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"17"},{"title":"Multimodal treatment of resectable pancreatic ductal adenocarcinoma","googleId":"zRtj5SBQkv8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816301901","googleCitationCount":24,"googleAuthor":"N Silvestris","doi":"10.1016/j.critrevonc.2017.01.015","elsevierAuthor":"Silvestris N.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"18"},{"title":"Current perspectives on the crosstalk between lung cancer stem cells and cancer-associated fibroblasts","googleId":"xMpe22LdDtYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304560","googleCitationCount":20,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.02.015","elsevierAuthor":"Alguacil-Núñez C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"14"},{"title":"Polymorphisms in non-coding RNAs and risk of colorectal cancer: A systematic review and meta-analysis","googleId":"yminuEa3grgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304444","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.09.003","elsevierAuthor":"Alidoust M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"12"},{"title":"Emergence of miR-34a in radiation therapy","googleId":"h443Yw5mWgoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303511","googleCitationCount":29,"googleAuthor":"J Lacombe","doi":"10.1016/j.critrevonc.2016.11.017","elsevierAuthor":"Lacombe J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"24"},{"title":"The role of anti-PD-1 and anti-PD-L1 agents in the treatment of diffuse large B-cell lymphoma: the future is now","googleId":"FEFlS9das7oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302396","googleCitationCount":25,"googleAuthor":"LM Juárez-Salcedo","doi":"10.1016/j.critrevonc.2017.02.027","elsevierAuthor":"Juárez-Salcedo L.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"17"},{"title":"Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: review of literature and future opportunities","googleId":"00c1KdpAfLkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300015","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.05.010","elsevierAuthor":"Hiemcke-Jiwa L.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"11"},{"title":"Relevance of small GTPase Rac1 pathway in drug and radio-resistance mechanisms: Opportunities in cancer therapeutics","googleId":"oFpSUgJMUH8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730327X","googleCitationCount":19,"googleAuthor":"DF Alonso","doi":"10.1016/j.critrevonc.2018.01.012","elsevierAuthor":"Cardama G.A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"12"},{"title":"Manipulating macrophage polarization and function using classical HDAC inhibitors: Implications for autoimmunity and inflammation","googleId":"xqej2o7BL8sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300131","googleCitationCount":15,"googleAuthor":"A Mohammadi","doi":"10.1016/j.critrevonc.2018.05.009","elsevierAuthor":"Mohammadi A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"13"},{"title":"Efficacy and toxicity profile of carfilzomib based regimens for treatment of multiple myeloma: A systematic review","googleId":"6P40QLnTRtoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303931","googleCitationCount":19,"googleAuthor":"V Kapoor","doi":"10.1016/j.critrevonc.2018.02.008","elsevierAuthor":"Mushtaq A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"13"},{"title":"Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders","googleId":"hOomrKbBpgoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304213","googleCitationCount":35,"googleAuthor":"MF Tolba","doi":"10.1016/j.critrevonc.2018.01.005","elsevierAuthor":"Tolba M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"21"},{"title":"Oral cancer in Fanconi anemia: Review of 121 cases","googleId":"WvUpLq152xUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303487","googleCitationCount":21,"googleAuthor":"JM Amenábar","doi":"10.1016/j.critrevonc.2018.02.013","elsevierAuthor":"Furquim C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"13"},{"title":"Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: a critical review","googleId":"mn6QygMQr5YJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302184","googleCitationCount":17,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.11.014","elsevierAuthor":"Savina M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"9"},{"title":"The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors","googleId":"aM4UBQMDxPgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302700","googleCitationCount":23,"googleAuthor":"NA Fonseca","doi":"10.1016/j.critrevonc.2017.03.016","elsevierAuthor":"Fonseca N.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"15"},{"title":"Mitochondrial dysfunctions in bladder cancer: exploring their role as disease markers and potential therapeutic targets","googleId":"SeUxDOaBK1wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301919","googleCitationCount":21,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.07.001","elsevierAuthor":"Cormio A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"17"},{"title":"Perioperative systemic therapy for resectable colorectal peritoneal metastases: sufficient evidence for its widespread use? A critical systematic review","googleId":"Sm5ebknXwmwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302426","googleCitationCount":23,"googleAuthor":"GA Simkens","doi":"10.1016/j.critrevonc.2017.03.028","elsevierAuthor":"Rovers K.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"19"},{"title":"Adiponectin: Its role in obesity-associated colon and prostate cancers","googleId":"ZwxL6BLFiHMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301038","googleCitationCount":25,"googleAuthor":"S Muppala","doi":"10.1016/j.critrevonc.2017.06.003","elsevierAuthor":"Muppala S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"22"},{"title":"EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde tale","googleId":"Erw-C8zo_tgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300349","googleCitationCount":15,"googleAuthor":"C Aguilar-Gallardo","doi":"10.1016/j.critrevonc.2018.03.006","elsevierAuthor":"Herreros-Pomares A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"10"},{"title":"The impact of long-term follow-up care for childhood cancer survivors: A systematic review","googleId":"nLkQMWA0RMYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300379","googleCitationCount":38,"googleAuthor":"C Signorelli","doi":"10.1016/j.critrevonc.2017.04.007","elsevierAuthor":"Signorelli C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"23"},{"title":"Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early Breast cancer: A systematic review and meta-analysis","googleId":"ajeatWNZYJgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302359","googleCitationCount":28,"googleAuthor":"R Greer","doi":"10.1016/j.critrevonc.2017.01.010","elsevierAuthor":"Roberts K.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"20"},{"title":"Hormone replacement therapy in cancer survivors: Utopia?","googleId":"otp_SKncCTEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302676","googleCitationCount":18,"googleAuthor":"S Capriglione","doi":"10.1016/j.critrevonc.2018.02.005","elsevierAuthor":"Angioli R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"11"},{"title":"Targeting androgen-independent pathways: new chances for patients with prostate cancer?","googleId":"DqlfA5Ta-6AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301932","googleCitationCount":20,"googleAuthor":"C Cattrini","doi":"10.1016/j.critrevonc.2017.08.009","elsevierAuthor":"Cattrini C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"16"},{"title":"Distance-delivered physical activity interventions for childhood cancer survivors: A systematic review and meta-analysis","googleId":"uWqS36jcHu4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730063X","googleCitationCount":20,"googleAuthor":"D Mizrahi","doi":"10.1016/j.critrevonc.2017.08.008","elsevierAuthor":"Mizrahi D.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"10"},{"title":"The predictive value of primary tumor location in patients with metastatic colorectal cancer: a systematic review","googleId":"AgG06-xJdEEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303098","googleCitationCount":32,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.11.003","elsevierAuthor":"Boeckx N.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"24"},{"title":"Palliative systemic therapy for recurrent or metastatic nasopharyngeal carcinoma–How far have we achieved?","googleId":"MFg0e0IB5XsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281630405X","googleCitationCount":23,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.03.030","elsevierAuthor":"Lee V.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"18"},{"title":"Immunotherapy for the treatment of multiple myeloma","googleId":"VX5Jdxa4CMkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302529","googleCitationCount":22,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.01.011","elsevierAuthor":"Jung S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"17"},{"title":"Recent developments and obstacles in the treatment of melanoma with BRAF and MEK inhibitors","googleId":"k8_SIdLFTPEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730481X","googleCitationCount":17,"googleAuthor":"M Wahid","doi":"10.1016/j.critrevonc.2018.03.005","elsevierAuthor":"Wahid M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"17"},{"title":"Paraoxonase-1 activity in patients with cancer: A systematic review and meta-analysis","googleId":"jieRGOPEJ5AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300684","googleCitationCount":16,"googleAuthor":"M Arenas","doi":"10.1016/j.critrevonc.2018.04.005","elsevierAuthor":"Arenas M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"15"},{"title":"ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer","googleId":"8YhHdzRn7N0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305759","googleCitationCount":19,"googleAuthor":"F Lordick","doi":"10.1016/j.critrevonc.2017.12.019","elsevierAuthor":"Allum W.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"15"},{"title":"The Therapeutic use of human albumin in cancer patients' management","googleId":"N_skc9ifpkQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303857","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.11.008","elsevierAuthor":"Moujaess E.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"16"},{"title":"Long-term toxicity of the treatment for germ cell-cancer. A review","googleId":"Pn6CmqAiRwgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303530","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.11.015","elsevierAuthor":"Maroto P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"13"},{"title":"Liver toxicity in the era of immune checkpoint inhibitors: a practical approach","googleId":"DaYcJfigsJ0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302853","googleCitationCount":11,"googleAuthor":"M Zuin","doi":"10.1016/j.critrevonc.2018.09.019","elsevierAuthor":"Belli C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"11"},{"title":"Management of salivary gland malignant tumor: the Policlinico Umberto I,“Sapienza” University of Rome Head and Neck Unit clinical recommendations","googleId":"MBU8BxT5DpAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303918","googleCitationCount":19,"googleAuthor":"M de Vincentiis","doi":"10.1016/j.critrevonc.2017.10.010","elsevierAuthor":"De Felice F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"12"},{"title":"PARP inhibitors alone and in combination with other biological agents in homologous recombination deficient epithelial ovarian cancer: From the basic research to the …","googleId":"Xwlyko2urYQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816304036","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.04.006","elsevierAuthor":"Gadducci A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"17"},{"title":"The emerging co-regulatory role of long noncoding RNAs in epithelial-mesenchymal transition and the Warburg effect in aggressive tumors","googleId":"VLAUwCkktKoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300106","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.028","elsevierAuthor":"Hua Q.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"10"},{"title":"The influence of genetic variation on late toxicities in childhood cancer survivors: A review","googleId":"ok4RJDn1SxkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730567X","googleCitationCount":18,"googleAuthor":"ALF van der Kooi","doi":"10.1016/j.critrevonc.2018.04.001","elsevierAuthor":"Clemens E.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"13"},{"title":"The ethical plausibility of the 'Right To Try'laws","googleId":"rb7ArQZiqJwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304420","googleCitationCount":17,"googleAuthor":"D Carrieri","doi":"10.1016/j.critrevonc.2017.12.014","elsevierAuthor":"Carrieri D.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"8"},{"title":"SPARCL1 a novel player in cancer biology","googleId":"X5fXWcu6NEoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302530","googleCitationCount":23,"googleAuthor":"A Narayanan","doi":"10.1016/j.critrevonc.2016.11.013","elsevierAuthor":"Gagliardi F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"18"},{"title":"5-Lipoxygenase: its involvement in gastrointestinal malignancies","googleId":"hK9RUkZXINEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301434","googleCitationCount":13,"googleAuthor":"N Merchant","doi":"10.1016/j.critrevonc.2018.05.012","elsevierAuthor":"Merchant N.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"10"},{"title":"Advances in the management of HER2-positive early breast cancer","googleId":"2v4V-e5gMaMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303517","googleCitationCount":35,"googleAuthor":"RE Coleman","doi":"10.1016/j.critrevonc.2017.10.001","elsevierAuthor":"Baselga J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"20"},{"title":"Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard?","googleId":"yUTym11Riz0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301531","googleCitationCount":22,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.03.008","elsevierAuthor":"Veereman G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"15"},{"title":"Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); A new perspective in the era of immunotherapy","googleId":"Vku0Qb26YFoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300306","googleCitationCount":26,"googleAuthor":"NF Saba","doi":"10.1016/j.critrevonc.2017.04.011","elsevierAuthor":"Saba N.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"19"},{"title":"Combination of immune checkpoint inhibitors and radiotherapy: Review of the literature","googleId":"ibTXCkKbz7UJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301518","googleCitationCount":24,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.03.003","elsevierAuthor":"Sindoni A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"18"},{"title":"Organization, quality and cost of oncological home-hospitalization: A systematic review","googleId":"rhfCYY19gckJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304894","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.011","elsevierAuthor":"Cool L.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"7"},{"title":"Review of sequencing platforms and their applications in phaeochromocytoma and paragangliomas","googleId":"ZhQzQhkZW_cJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300665","googleCitationCount":37,"googleAuthor":"S Pillai","doi":"10.1016/j.critrevonc.2017.05.005","elsevierAuthor":"Pillai S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"17"},{"title":"Sarcoma–The standard-bearer in cancer discovery","googleId":"cRpZ7MhmcV0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300465","googleCitationCount":18,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.007","elsevierAuthor":"Potter J.W.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"9"},{"title":"Regulation of epithelial to mesenchymal transition by BRCA1 in breast cancer","googleId":"JK5tSGFgMjsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304535","googleCitationCount":18,"googleAuthor":"SK Sengodan","doi":"10.1016/j.critrevonc.2018.01.008","elsevierAuthor":"Sengodan S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"13"},{"title":"Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases","googleId":"kmTjbmmjaOQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302159","googleCitationCount":34,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.04.008","elsevierAuthor":"Body J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"25"},{"title":"Radiation therapy in renal cell carcinoma","googleId":"xKeso9lyhf0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300544","googleCitationCount":12,"googleAuthor":"V Tombolini","doi":"10.1016/j.critrevonc.2018.06.002","elsevierAuthor":"De Felice F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"8"},{"title":"EGFR inhibition in NSCLC: New findings…. and opened questions?","googleId":"2ngLrC2H_lMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300288","googleCitationCount":21,"googleAuthor":"M Castiglia","doi":"10.1016/j.critrevonc.2017.02.009","elsevierAuthor":"Passiglia F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"15"},{"title":"Mind and body practices for fatigue reduction in patients with cancer and hematopoietic stem cell transplant recipients: a systematic review and meta-analysis","googleId":"I-InBe2Vmx8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303888","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.11.011","elsevierAuthor":"Duong N.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"5"},{"title":"Enzastaurin: A lesson in drug development","googleId":"7qmcTRcBQc0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300537","googleCitationCount":19,"googleAuthor":"A Narendran","doi":"10.1016/j.critrevonc.2017.02.003","elsevierAuthor":"Bourhill T.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"16"},{"title":"The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis","googleId":"UQ_ZLVBA9r0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300325","googleCitationCount":13,"googleAuthor":"D Ciliberto","doi":"10.1016/j.critrevonc.2018.03.003","elsevierAuthor":"Ciliberto D.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"10"},{"title":"The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting","googleId":"KuzVNIGAuoUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300033","googleCitationCount":25,"googleAuthor":"N Jonckheere","doi":"10.1016/j.critrevonc.2017.01.002","elsevierAuthor":"Jonckheere N.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"20"},{"title":"Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG)","googleId":"jrzGP94JcFAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300653","googleCitationCount":30,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.10.013","elsevierAuthor":"Gwak H.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"17"},{"title":"Emerging paradigms in the treatment of liver metastases in colorectal cancer","googleId":"MlBn8mGTS6YJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304079","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.09.011","elsevierAuthor":"Alhumaid A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"10"},{"title":"Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer","googleId":"T_HPMEn5SJAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305632","googleCitationCount":14,"googleAuthor":"A Ranjan","doi":"10.1016/j.critrevonc.2018.03.016","elsevierAuthor":"Hurtado M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"11"},{"title":"Radiotherapy in the age of cancer immunology: current concepts and future developments","googleId":"lqTliZiS8V0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300525","googleCitationCount":19,"googleAuthor":"M Loi","doi":"10.1016/j.critrevonc.2017.02.002","elsevierAuthor":"Loi M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"14"},{"title":"Positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning in anal cancer: a systematic review and meta-analysis","googleId":"PwOVtINyAkQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304699","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.013","elsevierAuthor":"Albertsson P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"10"},{"title":"A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting","googleId":"MgkPjZyEgzMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302196","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.11.012","elsevierAuthor":"Singh K.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"11"},{"title":"The identification and isolation of CTCs: a biological Rubik's cube","googleId":"AdV0fTpsxjsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304201","googleCitationCount":15,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.027","elsevierAuthor":"Mansilla C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"12"},{"title":"Concern over cost of and access to cancer treatments: a meta-narrative review of nivolumab and pembrolizumab studies","googleId":"CN2vvCAqeZgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301471","googleCitationCount":12,"googleAuthor":"CP da Veiga","doi":"10.1016/j.critrevonc.2018.07.002","elsevierAuthor":"da Veiga C.R.P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"11"},{"title":"A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?","googleId":"wv9NFGpxZ8oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303980","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.05.008","elsevierAuthor":"Vos S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"11"},{"title":"Follow-up program in head and neck cancer","googleId":"g_BnyB1yjmgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301725","googleCitationCount":21,"googleAuthor":"M de Vincentiis","doi":"10.1016/j.critrevonc.2017.03.012","elsevierAuthor":"De Felice F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"18"},{"title":"Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma","googleId":"apsiDglKSUsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300908","googleCitationCount":11,"googleAuthor":"I Elmaci","doi":"10.1016/j.critrevonc.2018.06.004","elsevierAuthor":"Elmaci I.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"8"},{"title":"Clinical update on K-Ras targeted therapy in gastrointestinal cancers","googleId":"FLOkaUAI5nMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281830221X","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.07.011","elsevierAuthor":"Pant S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"8"},{"title":"Prediction models for endometrial cancer for the general population or symptomatic women: A systematic review","googleId":"ZHBTW4gC5uEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305024","googleCitationCount":12,"googleAuthor":"N Pashayan","doi":"10.1016/j.critrevonc.2018.03.023","elsevierAuthor":"Alblas M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"9"},{"title":"Tumor infiltrating lymphocytes in gastrointestinal tumors: Controversies and future clinical implications","googleId":"OipjIt9ci7UJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303389","googleCitationCount":25,"googleAuthor":"","doi":"10.1016/j.critrevonc.2016.11.016","elsevierAuthor":"Solinas C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"21"},{"title":"Mathematical modeling of cancer metabolism","googleId":"H4PL3Jbe6ucJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303967","googleCitationCount":12,"googleAuthor":"MÁ Medina","doi":"10.1016/j.critrevonc.2018.02.004","elsevierAuthor":"Medina M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"7"},{"title":"Total antioxidant capacity in beta-thalassemia: a systematic review and meta-analysis of case-control studies","googleId":"CY9jpzFCQeYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303699","googleCitationCount":20,"googleAuthor":"M Palmery","doi":"10.1016/j.critrevonc.2016.12.007","elsevierAuthor":"Manafikhi H.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"11"},{"title":"Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: a pooled analysis","googleId":"NOh9_Vmu3ogJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300143","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.07.003","elsevierAuthor":"Bringhen S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"9"},{"title":"Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel …","googleId":"QD-U9rln9ekJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302336","googleCitationCount":14,"googleAuthor":"C van Marcke","doi":"10.1016/j.critrevonc.2018.09.009","elsevierAuthor":"van Marcke C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"8"},{"title":"Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma","googleId":"Bo_EUxdy9bgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305036","googleCitationCount":14,"googleAuthor":"FG Foschi","doi":"10.1016/j.critrevonc.2018.06.017","elsevierAuthor":"Canale M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"10"},{"title":"The molecular genetics of chemotherapy–induced peripheral neuropathy: A systematic review and meta-analysis","googleId":"BKKE8P7-ujgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301166","googleCitationCount":30,"googleAuthor":"F Azam","doi":"10.1016/j.critrevonc.2017.09.009","elsevierAuthor":"Cliff J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"25"},{"title":"Supporting supportive care in cancer: the ethical importance of promoting a holistic conception of quality of life","googleId":"fTDzhni-i24J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818303068","googleCitationCount":11,"googleAuthor":"D Carrieri","doi":"10.1016/j.critrevonc.2018.09.002","elsevierAuthor":"Carrieri D.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"5"},{"title":"Emerging roles for long noncoding RNAs in B-cell development and malignancy","googleId":"dV0UjsMfY_wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730402X","googleCitationCount":30,"googleAuthor":"A Diepstra","doi":"10.1016/j.critrevonc.2017.08.011","elsevierAuthor":"Winkle M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"19"},{"title":"Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer","googleId":"dFxV20A6qSMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302130","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.06.011","elsevierAuthor":"Trestini I.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"8"},{"title":"One step ahead: miRNA-34 in colon cancer-future diagnostic and therapeutic tool?","googleId":"tmO6d1N3X6wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304675","googleCitationCount":11,"googleAuthor":"J Fichna","doi":"10.1016/j.critrevonc.2018.09.006","elsevierAuthor":"Krajewska J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"10"},{"title":"Immuno-oncology in GI tumours: clinical evidence and emerging trials of PD-1/PD-L1 antagonists","googleId":"UjVRLswuFlgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300118","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.07.001","elsevierAuthor":"Stein A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"10"},{"title":"Anthropometric factors and non-Hodgkin's lymphoma risk: systematic review and meta-analysis of prospective studies","googleId":"yGmMZOz2uOEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304882","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.05.018","elsevierAuthor":"Hidayat K.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"6"},{"title":"Impact of hyperglycemia on the efficacy of chemotherapy—A systematic review of preclinical studies","googleId":"3HzjHJ2XgNcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301567","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.03.007","elsevierAuthor":"Gerards M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"14"},{"title":"The relationship between body mass index and short term postoperative outcomes in patients undergoing potentially curative surgery for colorectal cancer: a …","googleId":"lQI_ySK5Kp0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303717","googleCitationCount":13,"googleAuthor":"ST McSorley","doi":"10.1016/j.critrevonc.2017.12.004","elsevierAuthor":"Almasaudi A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"10"},{"title":"Circulating tumor cells and coagulation—Minireview","googleId":"W3EZ3UirJm0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730197X","googleCitationCount":15,"googleAuthor":"B Bystricky","doi":"10.1016/j.critrevonc.2017.04.003","elsevierAuthor":"Bystricky B.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"9"},{"title":"Glucocorticoids as an adjunct to oncologic treatment in solid malignancies–not an innocent bystander","googleId":"Ay1xV2E1c5IJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730416X","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.015","elsevierAuthor":"Maurice-Dror C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"9"},{"title":"Trastuzumab uptake in HER2-positive breast cancer patients: a systematic review and meta-analysis of observational studies","googleId":"4jlENhabhisJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300957","googleCitationCount":10,"googleAuthor":"AP Martin","doi":"10.1016/j.critrevonc.2018.07.012","elsevierAuthor":"Martin A.P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"6"},{"title":"Metformin for non-small cell lung cancer patients: opportunities and pitfalls","googleId":"KZCV9kqLLi0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304985","googleCitationCount":11,"googleAuthor":"A Levy","doi":"10.1016/j.critrevonc.2018.03.001","elsevierAuthor":"Levy A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"10"},{"title":"Platelet-derived growth factor receptors (PDGFRs) fusion genes involvement in hematological malignancies","googleId":"CW5nsG-564cJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303249","googleCitationCount":19,"googleAuthor":"K Appiah-Kubi","doi":"10.1016/j.critrevonc.2016.11.008","elsevierAuthor":"Appiah-Kubi K.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"12"},{"title":"Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario","googleId":"K5_57tPvsXcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304857","googleCitationCount":12,"googleAuthor":"A Addeo","doi":"10.1016/j.critrevonc.2017.12.015","elsevierAuthor":"Addeo A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"0"},{"title":"Triplet versus doublet combination regimens for the treatment of relapsed or refractory multiple myeloma: A meta-analysis of phase III randomized controlled trials","googleId":"dd6FGordP0oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303122","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.03.018","elsevierAuthor":"Sun Z.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"11"},{"title":"Overcoming obstacles in the design of cancer anorexia/weight loss trials","googleId":"UijSDu7aCk0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301506","googleCitationCount":17,"googleAuthor":"WJ Evans","doi":"10.1016/j.critrevonc.2017.06.008","elsevierAuthor":"Le-Rademacher J.G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"11"},{"title":"Mechanism behind the anti-tumour potential of saffron (Crocus sativus L.): The molecular perspective","googleId":"mNDbW_BJdFEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302238","googleCitationCount":26,"googleAuthor":"M Sarwat","doi":"10.1016/j.critrevonc.2017.04.010","elsevierAuthor":"Patel S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"28"},{"title":"Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature","googleId":"a3wJDFP6l58J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305334","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.08.010","elsevierAuthor":"Francolini G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"6"},{"title":"Meeting the needs of breast cancer: A nucleolin's perspective","googleId":"YTKv5n7X1GUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303116","googleCitationCount":18,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.008","elsevierAuthor":"Gregório A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"12"},{"title":"Dose-dense weekly chemotherapy in advanced ovarian cancer: An updated meta-analysis of randomized controlled trials","googleId":"rX-WyMGoPdcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300027","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.02.016","elsevierAuthor":"Marchetti C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"11"},{"title":"Imaging performance in guiding response to neoadjuvant therapy according to breast cancer subtypes: A systematic literature review","googleId":"0c_BH_-DkmwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300823","googleCitationCount":17,"googleAuthor":"VP Retèl","doi":"10.1016/j.critrevonc.2017.02.014","elsevierAuthor":"Lindenberg M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"14"},{"title":"A revisited concept. Tumors: Wounds that do not heal","googleId":"DersNCENOAYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305656","googleCitationCount":10,"googleAuthor":"D Ribatti","doi":"10.1016/j.critrevonc.2018.05.016","elsevierAuthor":"Ribatti D.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"6"},{"title":"Pharmacokinetics variability: Why nanoparticles are not just magic-bullets in oncology","googleId":"f9nVq5yLMZMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301604","googleCitationCount":19,"googleAuthor":"A Rodallec","doi":"10.1016/j.critrevonc.2018.06.008","elsevierAuthor":"Rodallec A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"16"},{"title":"Serum and tissue markers in colorectal cancer: State of art","googleId":"lWj7bGRFmCEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300094","googleCitationCount":16,"googleAuthor":"M Berretta","doi":"10.1016/j.critrevonc.2017.01.007","elsevierAuthor":"Berretta M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"20"},{"title":"Kallistatin suppresses cancer development by multi-factorial actions","googleId":"bgBQYV2yt_YJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301713","googleCitationCount":16,"googleAuthor":"P Li","doi":"10.1016/j.critrevonc.2017.03.011","elsevierAuthor":"Chao J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"11"},{"title":"Treatment of squamous cell carcinoma of the anal canal: A new strategies with anti-EGFR therapy and immunotherapy","googleId":"xdkAn7QZZ5AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304419","googleCitationCount":11,"googleAuthor":"AC Gardini","doi":"10.1016/j.critrevonc.2018.01.007","elsevierAuthor":"Casadei Gardini A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"6"},{"title":"A systematic review of palliative bone radiotherapy based on pain relief and retreatment rates","googleId":"8_GK-OlZEdIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730433X","googleCitationCount":13,"googleAuthor":"A Paix","doi":"10.1016/j.critrevonc.2018.01.006","elsevierAuthor":"Pin Y.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"9"},{"title":"Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?","googleId":"GxSTxoNN2tEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301136","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.05.013","elsevierAuthor":"Frega S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"7"},{"title":"A question of class: treatment options for patients with relapsed and/or refractory multiple myeloma","googleId":"bHXvhWFKJmcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302214","googleCitationCount":21,"googleAuthor":"G Cook","doi":"10.1016/j.critrevonc.2017.11.016","elsevierAuthor":"Cook G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"15"},{"title":"C-MET as a potential target therapy toward personalized therapy in some pediatric tumors: An overview","googleId":"9UCsFQE6LU0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302555","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.08.007","elsevierAuthor":"Rashed W.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"6"},{"title":"Metabolic hijacking: A survival strategy cancer cells exploit?","googleId":"uS526pJ8gdsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302153","googleCitationCount":18,"googleAuthor":"AM Engelbrecht","doi":"10.1016/j.critrevonc.2016.11.010","elsevierAuthor":"Mitchell M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"15"},{"title":"Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors","googleId":"6cH7RMYUDAAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300507","googleCitationCount":7,"googleAuthor":"L Cheng","doi":"10.1016/j.critrevonc.2018.07.008","elsevierAuthor":"Carrozza F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"7"},{"title":"Insights into dovetailing GTD and Cancers","googleId":"BHoqPONgLsIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301968","googleCitationCount":13,"googleAuthor":"SK Sengodan","doi":"10.1016/j.critrevonc.2017.04.001","elsevierAuthor":"Nadhan R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"8"},{"title":"Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?","googleId":"E1uUhqz9_-0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730183X","googleCitationCount":24,"googleAuthor":"G Aprile","doi":"10.1016/j.critrevonc.2017.03.025","elsevierAuthor":"Aprile G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"16"},{"title":"Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps","googleId":"WoskXuTJ30MJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281830177X","googleCitationCount":7,"googleAuthor":"H Ten Cate","doi":"10.1016/j.critrevonc.2018.09.014","elsevierAuthor":"Leader A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"7"},{"title":"Clinical importance of DNA repair in sporadic colorectal cancer","googleId":"iRAgIhnbE6IJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304389","googleCitationCount":8,"googleAuthor":"J Saffi","doi":"10.1016/j.critrevonc.2018.03.017","elsevierAuthor":"Laporte G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"8"},{"title":"Biological and predictive role of ERCC1 polymorphisms in cancer","googleId":"UUgLl0gsoY0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302621","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.01.016","elsevierAuthor":"Formica V.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"10"},{"title":"Continuous therapy in standard-and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials","googleId":"Kvh3yzRDvcQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302178","googleCitationCount":7,"googleAuthor":"M D'Agostino","doi":"10.1016/j.critrevonc.2018.09.008","elsevierAuthor":"D'Agostino M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"4"},{"title":"ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta …","googleId":"TdBi7yuaM8UJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304821","googleCitationCount":12,"googleAuthor":"Y Urun","doi":"10.1016/j.critrevonc.2017.10.012","elsevierAuthor":"Urun Y.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"9"},{"title":"Bartholin gland cancer","googleId":"zra4PCSE3CgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302645","googleCitationCount":22,"googleAuthor":"V Di Donato","doi":"10.1016/j.critrevonc.2017.06.005","elsevierAuthor":"Di Donato V.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"0"},{"title":"Tafro syndrome: critical review for clinicians and pathologists","googleId":"WLdSHCJHTfQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303670","googleCitationCount":8,"googleAuthor":"S Paydas","doi":"10.1016/j.critrevonc.2018.05.015","elsevierAuthor":"Semra P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"6"},{"title":"A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short-and long-acting erythropoiesis-stimulating agents in …","googleId":"OV0BdO-FugYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281830132X","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.06.010","elsevierAuthor":"Arantes L.H.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"7"},{"title":"ETV6 and ETV7: Siblings in hematopoiesis and its disruption in disease","googleId":"4XbGi4SHNL8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301762","googleCitationCount":12,"googleAuthor":"P Rasighaemi","doi":"10.1016/j.critrevonc.2017.05.011","elsevierAuthor":"Rasighaemi P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"7"},{"title":"Interferon induced thrombotic microangiopathy (TMA): Analysis and concise review","googleId":"T3pyVBOu4GsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300793","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.02.011","elsevierAuthor":"Kundra A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"12"},{"title":"Treatment options for metastatic colorectal cancer in patients with liver dysfunction due to malignancy","googleId":"n6kUe2j64uwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303742","googleCitationCount":15,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.03.029","elsevierAuthor":"Faugeras L.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"10"},{"title":"Effectiveness of implementation strategies to increase physical activity uptake during and after cancer treatment","googleId":"x6NRZI35f90J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302172","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.09.005","elsevierAuthor":"IJsbrandy C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"8"},{"title":"Tackling endocrine resistance in ER-positive HER2-negative advanced breast cancer: A tale of imprecision medicine","googleId":"vYFcDfuDftAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303390","googleCitationCount":12,"googleAuthor":"A Matikas","doi":"10.1016/j.critrevonc.2017.04.002","elsevierAuthor":"Matikas A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"9"},{"title":"Determinants of bone specific metastasis in prostate cancer","googleId":"btCHw0xg0zIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302967","googleCitationCount":14,"googleAuthor":"P Manca","doi":"10.1016/j.critrevonc.2017.02.013","elsevierAuthor":"Manca P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"13"},{"title":"Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy …","googleId":"9hkeWraUOt0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303840","googleCitationCount":9,"googleAuthor":"P Bironzo","doi":"10.1016/j.critrevonc.2018.02.001","elsevierAuthor":"Di Maio M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"6"},{"title":"A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma origin","googleId":"FrM8ktcy2IsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302427","googleCitationCount":8,"googleAuthor":"E El Rassy","doi":"10.1016/j.critrevonc.2018.08.001","elsevierAuthor":"Kattan J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"7"},{"title":"Third-line systemic treatment versus best supportive care for advanced/metastatic gastric cancer: a systematic review and meta-analysis","googleId":"J7ZZOilFUlcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302391","googleCitationCount":20,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.05.002","elsevierAuthor":"Chan W.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"22"},{"title":"Evaluation and management of skeletal disease in cancer care","googleId":"uhfPPkVe1fkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302718","googleCitationCount":11,"googleAuthor":"A Kommalapati","doi":"10.1016/j.critrevonc.2017.09.003","elsevierAuthor":"Kommalapati A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"0"},{"title":"Ovarian cancer: Novel molecular aspects for clinical assessment","googleId":"n0hBmTokR_IJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301191","googleCitationCount":21,"googleAuthor":"R Palmirotta","doi":"10.1016/j.critrevonc.2017.06.007","elsevierAuthor":"Palmirotta R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"10"},{"title":"Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review","googleId":"1_JQHAxaQZkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305097","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.02.011","elsevierAuthor":"Kam T.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"0"},{"title":"GEORCC recommendations on target volumes in radiotherapy for Head Neck Cancer of Unkown Primary","googleId":"StkZoBxob-YJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305668","googleCitationCount":7,"googleAuthor":"JC Rodríguez","doi":"10.1016/j.critrevonc.2018.07.006","elsevierAuthor":"Cabrera Rodríguez J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"6"},{"title":"Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: critical review of the literature","googleId":"CKVqVXabVl4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303645","googleCitationCount":17,"googleAuthor":"O Annibali","doi":"10.1016/j.critrevonc.2018.02.003","elsevierAuthor":"Annibali O.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"14"},{"title":"Can we avoid the toxicity of chemotherapy in elderly cancer patients?","googleId":"r3g2OXIxvKoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302786","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.08.008","elsevierAuthor":"Feliu J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"14"},{"title":"Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease","googleId":"8vMZ6GbKXgwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301683","googleCitationCount":10,"googleAuthor":"F Alongi","doi":"10.1016/j.critrevonc.2017.07.004","elsevierAuthor":"Alongi F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"10"},{"title":"The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence","googleId":"Hph11jDzysgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303128","googleCitationCount":9,"googleAuthor":"A Perez-Rozos","doi":"10.1016/j.critrevonc.2017.12.007","elsevierAuthor":"Román A. A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"8"},{"title":"Criteria for eligibility to cisplatin in the curative treatment of head and neck cancer: consensus opinion from a panel of experts","googleId":"QnJw06BwlT0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300489","googleCitationCount":6,"googleAuthor":"G de Castro Jr","doi":"10.1016/j.critrevonc.2018.08.009","elsevierAuthor":"de Castro G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"5"},{"title":"The role of perineural invasion in predicting survival in patients with primary operable colorectal cancer: a systematic review","googleId":"9uRRLg1CwkgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300550","googleCitationCount":10,"googleAuthor":"HC Van Wyk","doi":"10.1016/j.critrevonc.2017.02.005","elsevierAuthor":"van Wyk H.C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"7"},{"title":"What is the role of postoperative re-irradiation in recurrent and second primary squamous cell cancer of head and neck? A literature review according to PICO criteria","googleId":"y-QNHsn15tsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302190","googleCitationCount":12,"googleAuthor":"A Merlotti","doi":"10.1016/j.critrevonc.2017.01.008","elsevierAuthor":"Merlotti A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"9"},{"title":"New perspectives in the second-line treatment of non squamous NSCLC patients: Results from a large Italian Lung Cancer Working Group","googleId":"5oCUz0xnydYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303377","googleCitationCount":14,"googleAuthor":"MR Migliorino","doi":"10.1016/j.critrevonc.2016.11.015","elsevierAuthor":"Cortinovis D.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"12"},{"title":"The role of endothelial colony forming cells in kidney cancer's pathogenesis, and in resistance to anti-VEGFR agents and mTOR inhibitors: A speculative review","googleId":"reo_LeDWAZ8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300532","googleCitationCount":16,"googleAuthor":"M Biggiogera","doi":"10.1016/j.critrevonc.2018.09.005","elsevierAuthor":"Poletto V.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"12"},{"title":"Going the distance: Are we losing patients along the multiple myeloma treatment pathway?","googleId":"Sk1KSRWXNu4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730478X","googleCitationCount":6,"googleAuthor":"E Terpos","doi":"10.1016/j.critrevonc.2018.03.021","elsevierAuthor":"Terpos E.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"4"},{"title":"The use of SAMe in chemotherapy-induced liver injury","googleId":"7ZQjvs96nNwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301793","googleCitationCount":15,"googleAuthor":"B Vincenzi","doi":"10.1016/j.critrevonc.2018.06.019","elsevierAuthor":"Vincenzi B.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"7"},{"title":"Interim 18FDG PET/CT during radiochemotherapy in the management of pelvic malignancies: a systematic review","googleId":"2l8YaadKVBEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300860","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.02.019","elsevierAuthor":"Ferrari M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"10"},{"title":"Targeting the tumor promoting effects of adenosine in chronic lymphocytic leukemia","googleId":"AU_OD6MW1ekJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305206","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.022","elsevierAuthor":"Cai Y.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"3"},{"title":"Potential application and prevalence of the CD30 (Ki-1) antigen among solid tumors: A focus review of the literature","googleId":"UWp4X8MC4fIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303274","googleCitationCount":9,"googleAuthor":"K Gee","doi":"10.1016/j.critrevonc.2017.02.021","elsevierAuthor":"Berger G.K.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"8"},{"title":"Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas","googleId":"lYgdjF2KD4QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300896","googleCitationCount":11,"googleAuthor":"B Vincenzi","doi":"10.1016/j.critrevonc.2017.06.006","elsevierAuthor":"Vincenzi B.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"11"},{"title":"Examining the bleeding incidences associated with targeted therapies used in metastatic renal cell carcinoma","googleId":"vjNSfMbaP3YJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730029X","googleCitationCount":8,"googleAuthor":"L Chablani","doi":"10.1016/j.critrevonc.2017.10.014","elsevierAuthor":"Crist M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"7"},{"title":"The etiopathogenesis of diffuse low-grade gliomas","googleId":"fQOF6OoLr5EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302165","googleCitationCount":12,"googleAuthor":"A Darlix","doi":"10.1016/j.critrevonc.2016.11.014","elsevierAuthor":"Darlix A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"9"},{"title":"p16 (INK4a) status and survival benefit of EGFR inhibitors in head and neck squamous cell cancer: a systematic review and meta-analysis","googleId":"2wxvo0QZBr4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304766","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.02.006","elsevierAuthor":"Su Y.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"4"},{"title":"Non pharmacological interventions and non-fentanyl pharmacological treatments for breakthrough cancer pain: A systematic and critical review","googleId":"wnOuEXQI56YJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304304","googleCitationCount":10,"googleAuthor":"S Mercadante","doi":"10.1016/j.critrevonc.2017.12.016","elsevierAuthor":"Mercadante S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"6"},{"title":"Duration of first-line treatment for metastatic colorectal cancer: translating the available evidence into general recommendations for routine practice","googleId":"5gH_A9wmhoEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300258","googleCitationCount":4,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.08.006","elsevierAuthor":"Morano F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"2"},{"title":"Treatment of spinal metastases in renal cell carcinoma: a critical review","googleId":"AXjMpD2juuwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304353","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.02.017","elsevierAuthor":"Teyssonneau D.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"5"},{"title":"Critical risk-benefit assessment of the novel anti-cancer aurora a kinase inhibitor alisertib (MLN8237): a comprehensive review of the clinical data","googleId":"dRp8GgXwYr8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302846","googleCitationCount":16,"googleAuthor":"Y Tayyar","doi":"10.1016/j.critrevonc.2017.09.006","elsevierAuthor":"Tayyar Y.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"14"},{"title":"Regulatory roles of brain-specific angiogenesis inhibitor 1 (BAI1) protein in inflammation, tumorigenesis and phagocytosis: A brief review","googleId":"4aIgI-Wqf4gJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300082","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.01.006","elsevierAuthor":"Mathema V.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"9"},{"title":"Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology","googleId":"oSoanM1YWPYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303104","googleCitationCount":14,"googleAuthor":"L Cheng","doi":"10.1016/j.critrevonc.2017.09.011","elsevierAuthor":"Sanfrancesco J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"12"},{"title":"Systematic review and survival meta-analysis of real world evidence on first-line pazopanib for metastatic renal cell carcinoma","googleId":"RYMnUvqTovsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303657","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.11.009","elsevierAuthor":"Climent M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"6"},{"title":"A network meta-analysis of the treatments for esophageal squamous cell carcinoma in terms of survival","googleId":"bgtnL8LwcmgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305723","googleCitationCount":6,"googleAuthor":"A Doosti-Irani","doi":"10.1016/j.critrevonc.2018.05.007","elsevierAuthor":"Doosti-Irani A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"6"},{"title":"Effect of anticoagulants on admission rates and length of hospital stay for acute venous thromboembolism: A systematic review of randomized control trials","googleId":"3FGlpGT9rnsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304328","googleCitationCount":5,"googleAuthor":"Y Hong","doi":"10.1016/j.critrevonc.2018.02.010","elsevierAuthor":"Hong Y.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"2"},{"title":"Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature","googleId":"wt40cO_WSMMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300781","googleCitationCount":9,"googleAuthor":"F Alongi","doi":"10.1016/j.critrevonc.2017.02.010","elsevierAuthor":"Alongi F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"7"},{"title":"The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity","googleId":"ibp6dflX2UkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301129","googleCitationCount":9,"googleAuthor":"R Corvò","doi":"10.1016/j.critrevonc.2017.05.012","elsevierAuthor":"Bossi P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"0"},{"title":"Review of current evidence available for guiding optimal Enoxaparin prophylactic dosing strategies in obese patients—actual weight-based vs fixed","googleId":"xS4_oOowb0gJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301816","googleCitationCount":9,"googleAuthor":"H Morrissey","doi":"10.1016/j.critrevonc.2017.03.022","elsevierAuthor":"He Z.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"5"},{"title":"The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis","googleId":"oWBHS4jAuToJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303244","googleCitationCount":5,"googleAuthor":"K Appiah-Kubi","doi":"10.1016/j.critrevonc.2018.05.004","elsevierAuthor":"Qian H.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"5"},{"title":"Unravelling the complexity of signalling networks in cancer: A review of the increasing role for computational modelling","googleId":"Gqgkfcc17A4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303250","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.06.004","elsevierAuthor":"Garland J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"7"},{"title":"Hand-foot skin reaction with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: A systematic review and meta-analysis","googleId":"8bHi-hmt-KcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730272X","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.09.016","elsevierAuthor":"Li J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"9"},{"title":"Fertility management for malignant ovarian germ cell tumors patients","googleId":"ShaR2zNpbmAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302536","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.10.005","elsevierAuthor":"Di Tucci C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"8"},{"title":"Overcoming immunosuppression in bone metastases","googleId":"zsXp7zb7NWEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301798","googleCitationCount":12,"googleAuthor":"ZZ Reinstein","doi":"10.1016/j.critrevonc.2017.05.004","elsevierAuthor":"Reinstein Z.Z.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"10"},{"title":"Overcoming barriers to treating iron overload in patients with lower-risk myelodysplastic syndrome","googleId":"4phZLaJ69ZsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300471","googleCitationCount":10,"googleAuthor":"AM Zeidan","doi":"10.1016/j.critrevonc.2017.07.002","elsevierAuthor":"Zeidan A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"7"},{"title":"Recent advances in genitourinary tumors: a review focused on biology and systemic treatment","googleId":"JxLhFDzfK3kJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730166X","googleCitationCount":13,"googleAuthor":"J Puente","doi":"10.1016/j.critrevonc.2017.03.010","elsevierAuthor":"González del Alba A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"11"},{"title":"Multimodality treatment of locally advanced squamous cell carcinoma of the oesophagus: A comprehensive review and network meta-analysis","googleId":"uxvWvsVekJsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302451","googleCitationCount":8,"googleAuthor":"P Frumento","doi":"10.1016/j.critrevonc.2017.03.024","elsevierAuthor":"Montagnani F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"June 2017","elsevierCitationCount":"7"},{"title":"Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: a systematic review and meta-analysis","googleId":"hrEfmma8WWoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302452","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.07.004","elsevierAuthor":"Di Nunno V.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"8"},{"title":"A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients","googleId":"M7848k-KK5QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300574","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.12.010","elsevierAuthor":"Baratelli C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"6"},{"title":"Clinical pharmacology of anti-angiogenic drugs in oncology","googleId":"gr1FfK2ys9cJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730255X","googleCitationCount":5,"googleAuthor":"J Wassermann","doi":"10.1016/j.critrevonc.2017.08.010","elsevierAuthor":"Gougis P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"4"},{"title":"Precision medicine for early breast cancer radiotherapy: opening up new horizons?","googleId":"iRX9VUi4EmIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300380","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.03.015","elsevierAuthor":"Bernier J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"5"},{"title":"Classic biphasic pulmonary blastoma: a case report and review of the literature","googleId":"usT31uj14CIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303006","googleCitationCount":4,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.02.009","elsevierAuthor":"Le Caer H.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"3"},{"title":"Patterns and drivers of health care use in long-term childhood cancer survivors: A systematic review","googleId":"S0yayeft-yYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302597","googleCitationCount":6,"googleAuthor":"RDA Lourenco","doi":"10.1016/j.critrevonc.2017.10.004","elsevierAuthor":"van Breeschoten J.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"3"},{"title":"Treatment of the axilla in patients with primary breast cancer and low burden axillary disease: Limitations of the evidence from randomised controlled trials","googleId":"PXhxgQPxSe8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303341","googleCitationCount":8,"googleAuthor":"PJJ Herrod","doi":"10.1016/j.critrevonc.2016.11.011","elsevierAuthor":"Robertson J.F.R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"7"},{"title":"Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment","googleId":"GWiM81whB1QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730358X","googleCitationCount":4,"googleAuthor":"M Del Re","doi":"10.1016/j.critrevonc.2018.03.002","elsevierAuthor":"Del Re M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"4"},{"title":"Oesophageal cancer: Which treatment is the easiest to swallow? A review of combined modality treatments for resectable carcinomas","googleId":"EAYz_tZscisJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730152X","googleCitationCount":8,"googleAuthor":"L Marcu","doi":"10.1016/j.critrevonc.2017.03.004","elsevierAuthor":"So B.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"8"},{"title":"The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients …","googleId":"GThyfSoPFi0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302251","googleCitationCount":10,"googleAuthor":"A Galvano","doi":"10.1016/j.critrevonc.2017.09.008","elsevierAuthor":"Rizzo S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"7"},{"title":"“No pain, No gain” still true with immunotherapy: When the finger shows the moon, look at the moon!","googleId":"dxb4GM9Dt3AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305401","googleCitationCount":3,"googleAuthor":"F Innocenti","doi":"10.1016/j.critrevonc.2018.04.003","elsevierAuthor":"Milano G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"3"},{"title":"Role of vena cava filters for the management of cancer-related venous thromboembolism: systematic review and meta-analysis","googleId":"oN4Msm5EmA8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300052","googleCitationCount":6,"googleAuthor":"CM Rojas-Hernandez","doi":"10.1016/j.critrevonc.2018.07.005","elsevierAuthor":"Rojas-Hernandez C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"1"},{"title":"The role of PDGF-B/PDGFR-BETA axis in the normal development and carcinogenesis of the breast","googleId":"IgESlU0sB-YJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300842","googleCitationCount":10,"googleAuthor":"AM Cîmpean","doi":"10.1016/j.critrevonc.2018.08.002","elsevierAuthor":"Jitariu A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"7"},{"title":"Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers","googleId":"EyWuPSR9FUcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305735","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.05.011","elsevierAuthor":"Di Tucci C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"3"},{"title":"Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato …","googleId":"fTeMCktrqdoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817305395","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.020","elsevierAuthor":"Shumilov E.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"3"},{"title":"Developing drugs in cancer-related bone pain","googleId":"yM8eGARmuNsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302202","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.08.005","elsevierAuthor":"Lucchesi M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"7"},{"title":"Imaging predictors of treatment outcomes in rectal cancer: An overview","googleId":"8ptYmAmEXs8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300167","googleCitationCount":3,"googleAuthor":"LS Mahadevan","doi":"10.1016/j.critrevonc.2018.06.009","elsevierAuthor":"ShreeMahadevan L.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"February 2019","elsevierCitationCount":"0"},{"title":"Critical review of axillary recurrence in early breast cancer","googleId":"bgmZZtNfLlQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303043","googleCitationCount":4,"googleAuthor":"CA Castaneda","doi":"10.1016/j.critrevonc.2018.06.013","elsevierAuthor":"Castaneda C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"3"},{"title":"Challenges and methodology in the incorporation of biomarkers in cancer clinical trials","googleId":"nlT4gIumEkwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303730","googleCitationCount":6,"googleAuthor":"CS Wilhelm-Benartzi","doi":"10.1016/j.critrevonc.2016.12.008","elsevierAuthor":"Wilhelm-Benartzi C.S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"5"},{"title":"Reappraisal of primary hepatic lymphoma: is surgical resection underestimated?","googleId":"9b6nwB2ySKIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300616","googleCitationCount":4,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.01.004","elsevierAuthor":"Cesaretti M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"4"},{"title":"To resect or not to resect: the hamletic dilemma of primary tumor resection in patients with asymptomatic stage IV colorectal cancer","googleId":"moqEzhGWZpEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302014","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.10.001","elsevierAuthor":"Gelsomino F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"1"},{"title":"Loco-regional treatment for castration-resistant prostate cancer: Is there any rationale? A critical review from the AFU-GETUG","googleId":"efJtsjbL6jUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817301841","googleCitationCount":4,"googleAuthor":"Y Loriot","doi":"10.1016/j.critrevonc.2017.12.012","elsevierAuthor":"Beauval J.B.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"4"},{"title":"A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives","googleId":"PJzNvUizoTcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817303256","googleCitationCount":3,"googleAuthor":"R Dionigi","doi":"10.1016/j.critrevonc.2018.10.002","elsevierAuthor":"Chiappa A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"2"},{"title":"Application of metabolomics in sarcoma: From biomarkers to therapeutic targets","googleId":"-aNrGTrNC1wJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527996/","googleCitationCount":7,"googleAuthor":"E Choy"},{"title":"Incidence and clinical parameters associated with eribulin mesylate-induced peripheral neuropathy","googleId":"p6mUyYvnHr4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818300568","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.06.003","elsevierAuthor":"Zhao B.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"0"},{"title":"The role of Cancer/Testis Antigens in Multiple Myeloma pathogenesis and their application in disease monitoring and therapy","googleId":"hkqj-NFzTX4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302671","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.09.010","elsevierAuthor":"Shires K.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"1"},{"title":"Brain metastases from non-small cell lung carcinoma: Changing concepts for improving patients' outcome","googleId":"u5ASRBCsHUoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300872","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.05.007","elsevierAuthor":"Rancoule C.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"5"},{"title":"Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: Has it yet become state-of-the-art?","googleId":"ptEQVkdROLoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304432","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.09.014","elsevierAuthor":"Van Der Weijst L.","publicationName":"Frontiers in Oncology","elsevierCoverDate":"2019-08-12","elsevierCoverDisplayDate":"12 August 2019","elsevierCitationCount":"0"},{"title":"When and how to treat women with HER2-positive, small (pT1a-b), node-negative breast cancer?","googleId":"100xc5BsXCgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730505X","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.03.010","elsevierAuthor":"Gori S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"1"},{"title":"Risk assessment in paediatric glioma—Time to move on from the binary classification","googleId":"T1DAVWYDMvwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302128","googleCitationCount":2,"googleAuthor":"JR Hansford","doi":"10.1016/j.critrevonc.2017.01.012","elsevierAuthor":"Dodgshun A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"2"},{"title":"Is still there a place for orteronel in management of prostate cancer? Data from a literature based meta-analysis of randomized trials","googleId":"sIX8PNaZqTwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816303146","googleCitationCount":2,"googleAuthor":"G Roviello","doi":"10.1016/j.critrevonc.2017.02.023","elsevierAuthor":"Roviello G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"2"},{"title":"Lipid metabolism and lung cancer.","googleId":"EBBg7Vc0GgMJ","googleLink":"https://europepmc.org/article/med/28325263","googleCitationCount":5,"googleAuthor":""},{"title":"A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting …","googleId":"Hs4eOkMW630J","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816302979","googleCitationCount":3,"googleAuthor":"MA West","doi":"10.1016/j.critrevonc.2017.02.008","elsevierAuthor":"West M.A.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"2"},{"title":"Role of bevacizumab in uterine leiomyosarcoma","googleId":"875-j8ROMMkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817302226","googleCitationCount":3,"googleAuthor":"G Bogani","doi":"10.1016/j.critrevonc.2018.03.019","elsevierAuthor":"Bogani G.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"1"},{"title":"Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review","googleId":"CtO4etAaV4wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S104084281730361X","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.02.014","elsevierAuthor":"Rivoirard R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"1"},{"title":"Quality of reporting in oncology studies: A systematic analysis of literature reviews and prospects","googleId":"3DZLu3Vt_AIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817300811","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.02.012","elsevierAuthor":"Rivoirard R.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"2"},{"title":"Evolution of randomized controlled trials and surrogacy of progression-free survival in advanced/metastatic urothelial cancer","googleId":"V7FGNDhv9pcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818301689","googleCitationCount":0,"googleAuthor":"S Zhang","doi":"10.1016/j.critrevonc.2018.07.007","elsevierAuthor":"Liang F.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"0"},{"title":"Do SABR-related toxicities for lung cancer depend on treatment delivery?","googleId":"Zk6ESv7JisQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842817304481","googleCitationCount":0,"googleAuthor":"LG Marcu","doi":"10.1016/j.critrevonc.2018.06.014","elsevierAuthor":"Morias S.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"0"},{"title":"Corrigendum to “The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity”(Critical Reviews in …","googleId":"icOPE_4UTJYJ","googleLink":"https://moh-it.pure.elsevier.com/en/publications/corrigendum-to-the-vicious-circle-of-treatment-induced-toxicities","googleCitationCount":0,"googleAuthor":"R Corvò","doi":"10.1016/j.critrevonc.2017.09.012","elsevierAuthor":"Bossi P.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"0"},{"title":"Corrigendum to “Evaluation and management of skeletal disease in cancer care”","googleId":"tW5rNA4HtRUJ","googleLink":"https://www.researchgate.net/profile/Ricardo_Correa3/publication/323526879_Corrigendum_to_Evaluation_and_management_of_skeletal_disease_in_cancer_care_Crit_Rev_OncolHematol_120_December_2017_217-226/links/5fb771aa458515b79755951e/Corrigendum-to-Evaluation-and-management-of-skeletal-disease-in-cancer-care-Crit-Rev-Oncol-Hematol-120-December-2017-217-226.pdf","googleCitationCount":0,"googleAuthor":"A Kommalapati"},{"title":"Pembrolizumab's non-cross resistance mechanism of action successfully overthrown ipilimumab","googleId":"mmocVLrJmAQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842816301986","googleCitationCount":2,"googleAuthor":"M Wahid","doi":"10.1016/j.critrevonc.2017.01.001","elsevierAuthor":"Wahid M.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"2"},{"title":"Erratum to\" Systematic Literature Review of Health-Related Quality of Life in Locally-Advanced Non-Small Cell Lung Cancer: Has It Yet Become State-Of-The-Art?\" …","googleId":"wstWam-o0RcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29055771/","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.critrevonc.2017.10.006,","elsevierAuthor":"van der Weijst L.","publicationName":"Critical Reviews in Oncology/Hematology","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"1"},{"title":"WITHDRAWN: Addition of targeted agents to chemotherapy for persistent or recurrent ovarian cancer: a meta-analysis of randomized controlled trials","googleId":"wFY8ry7JRKEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S1040842818302543","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.critrevonc.2018.06.020","elsevierCitationCount":0}]